 NEWTOWN, Pa., Sept. 14, 2021 GLOBE NEWSWIRE -- Helius Medical Technologies, Inc. Nasdaq:HSDT Helius or the Company, a neurotech company focused on neurological wellness, today announced the appointment of Paul Buckman to its Board of Directors, effective September 10, 2021. Mr. Buckman will serve as Chair of the Companys Audit Committee and as a member of its Compensation and Nominating Governance Committees. 